[Cardioembolic stroke: epidemiology]

Neurologia. 2012 Mar:27 Suppl 1:4-9. doi: 10.1016/S0213-4853(12)70002-6.
[Article in Spanish]

Abstract

Approximately one in four ischemic strokes is of cardioembolic origin. Non-valvular atrial fibrillation accounts for 50% of these cases, followed by myocardial infarction, intraventricular thrombus, valvular heart disease and a miscellany of causes. The incidence of embolic heart disease in the population could be about 30 cases per 100,000 inhabitants per year, and its prevalence between 5 and 10 cases per 1,000 persons aged 65 years or older. Hospital mortality is high, and 5-year survival is only one out of every five patients. The recurrence rate of this type of stroke is about 12% at 3 months, higher than that of non-cardioembolic stroke. The severity of cardioembolic strokes and the resulting disability are greater than with non-cardioembolic stroke. Age, a history of stroke or transient ischemic attack, hypertension, diabetes and heart failure play a role in stroke with atrial fibrillation as additional risk factors for future embolisms. Stroke rates can reach over 20% per year and therefore the prevention and treatment of these events are of paramount importance.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Age Distribution
  • Atrial Fibrillation / complications
  • Brain Damage, Chronic / epidemiology
  • Brain Damage, Chronic / etiology
  • Brain Ischemia / epidemiology
  • Brain Ischemia / etiology
  • Brain Ischemia / prevention & control
  • Cardiovascular Agents / therapeutic use
  • Comorbidity
  • Diabetes Mellitus / epidemiology
  • Female
  • Heart Valve Diseases / complications
  • Humans
  • Hypertension / epidemiology
  • Intracranial Embolism / epidemiology*
  • Intracranial Embolism / etiology
  • Intracranial Embolism / prevention & control
  • Male
  • Myocardial Infarction / complications
  • Prevalence
  • Recurrence
  • Risk Factors
  • Sex Distribution
  • Survival Rate
  • Thrombophilia / etiology

Substances

  • Cardiovascular Agents